Menicon Company (7780) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
7 Aug, 2026Market overview and trends
Vision care dominates sales, accounting for 92.8% of consolidated revenue, with healthcare and life care at 7.2%.
The global myopia population is rising, projected to reach 52% of the world population by 2050.
The Japanese contact lens market reached JPY 316.0 billion in FY2025, with a 20% group share.
1-DAY lenses represent 26.9% of sales, with lens care products at 54.3%.
The global contact lens market is expanding, with increasing shipment values across regions.
Business model and key strategies
MELS Plan subscription model offers fixed pricing and flexible lens replacement, driving customer retention.
Expansion of 1-DAY lens sales globally, supported by increased production capacity in Japan, Singapore, and Malaysia.
Orthokeratology lenses are promoted globally, with tailored strategies for Europe, North America, China, and Asia.
Strengthening sales channels with 1,641 MELS Plan member shops as of March 2026.
M&A activity has expanded the global network and product offerings, including recent acquisitions in Europe and Asia.
Product portfolio and innovation
Wide range of contact lenses: 1-DAY, 2-WEEK, 1-MONTH, 3-MONTH, and hard lenses, with monthly fees ranging from JPY 2,100 to 5,900.
Innovative packaging for 1-DAY lenses enables hygienic and easy handling.
Product lineups include silicone hydrogel, toric, multifocal, and color lenses.
Lens care products are sold as sets with orthokeratology lenses, especially in Asia.
Functional and customizable lenses are emphasized to meet diverse customer needs.
Latest events from Menicon Company
- Aims for global leadership in 1-DAY lenses and myopia control with strong growth and ESG focus.7780
Corporate presentation - Strong sales and profit growth driven by daily disposable and orthokeratology lenses.7780
Q1 2027 - Strong 1-DAY lens demand and MELS Plan subscriptions drive global growth and market expansion.7780
Investor presentation - Sales and profits rose on strong daily disposable lens demand and global expansion.7780
Q4 2026 - Profit and sales rose, driven by daily disposable lens growth and global expansion.7780
Q3 2026 - 1-DAY lens sales and price hikes lifted sales, but profits fell on higher costs and FX losses.7780
Q2 2026 - Profits fell sharply despite stable sales, as investments and FX losses weighed on margins.7780
Q1 2026 - Sales and profits rose on strong lens demand, with margin pressure expected ahead.7780
Q2 2025 - Sales and profit rose on Vision Care strength, with robust full-year outlook maintained.7780
Q1 2025